Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,575.56
(
-0.74%
)
US TECH 100
23,629.20
(
-0.70%
)
Dow Jones
45,809.63
(
-0.90%
)
Brent Oil
108.83
(
2.11%
)
Bitcoin
69,209.01
(
-2.85%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 145897

Monday, 07/23/2012 6:53:11 PM

Monday, July 23, 2012 6:53:11 PM

Post# of 257259
Re: Bapineuzumab results

…there must not have been a hint of efficacy if they also dropped the patients out of the extension study…

That’s consistent with this statement in the PR:

The [PFE-JNJ] Alliance will expedite the completion of an interim analysis for the on-going, Pfizer-conducted Phase 3 study of ApoE4 carriers (Study 3001) based on the results of Study 302.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today